Executive Summary

Oct 2019
PROSPECTS
Inflation continues to negatively affect dermatologicals but the category is still benefiting from innovation

Inflation is a major issue currently affecting dermatologicals in Argentina. As well as inflation resulting from the current economic reforms, the effects of the devaluation of the Argentinian peso in mid-2018 are still being felt, producing escalating inflationary pressure.

Argentinians looking both for good bargains but also products offering value-added benefits

Consumers continued to concentrate on getting the best value for money when buying dermatologicals, with many purchasing more affordable items in several categories so as to adapt to the unstable economic climate in Argentina. Nevertheless, innovative products, or those that offer significant value-added benefits, continued to be well received by consumers, who were willing to pay a little extra for such products.

Increasing presence of internet retailers

Although health and beauty specialist retailers, predominantly chemists/pharmacies, continue to dominate sales of dermatologicals, there is an increasing presence of internet retailers. Internet sales of dermatological products registered strong growth over the review period, albeit in large part due to starting from a very low base.

COMPETITIVE LANDSCAPE
Genomma Laboratories Argentina holds a strong position in dermatologicals

Despite having a relatively short history in the category, being present only since 2010, Genomma Laboratories Argentina is now the clear leader in dermatologicals, having successfully displaced other companies as a result of its strong advertising investment in its flagship brands Cicatricure, Piecidex and Unesia.

Investment in advertising key to success

The high level of competitiveness in dermatologicals is driven by multinational companies, which invest in local innovation, supported by strong advertising investment. Dermatological products enjoy strong advertising investment, particularly in antiparasitics/lice (head and body) treatments and topical germicides/antiseptics.

Private label and generics

Private label remains an underdeveloped area, with this situation not expected to change significantly over the short term. Branded products continue to account for the largest share of value sales, with generics becoming more common in topical antifungals and topical germicidals/antiseptics.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Argentina

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Argentina with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Argentina, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Argentina market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Argentina?
  • What are the major brands in Argentina?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Argentina - Category analysis

HEADLINES

PROSPECTS

Inflation continues to negatively affect dermatologicals but the category is still benefiting from innovation
Argentinians looking both for good bargains but also products offering value-added benefits
Increasing presence of internet retailers

COMPETITIVE LANDSCAPE

Genomma Laboratories Argentina holds a strong position in dermatologicals
Investment in advertising key to success
Private label and generics

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Argentina - Industry Overview

EXECUTIVE SUMMARY

Consumer health still growing, but at slower rates in 2019
Consumer health expenditure continues increasing
No change at the top, as Bayer, Arcor and Abbott continue to lead
Direct selling performing well against the backdrop of high inflation rates
Further growth expected in consumer health over the forecast period

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources